Oncothyreon Inc.

Oncothyreon Inc. is a biotechnology company based in Seattle, Washington, specializing in the development of innovative cancer therapies. The organization focuses on harnessing the immune system to target and destroy cancer cells, with a commitment to advancing treatments for various types of cancer. Through its research, Oncothyreon aims to improve patient outcomes and contribute to the evolving landscape of oncology, leveraging cutting-edge technologies and scientific expertise in the field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#202 in Seattle, WA

#687 in Washington

#29,892 in US

#56,119 in the World

Seattle, WA, United States of America

Oncothyreon Inc.

Forward Citations = 58

15 inventors:

B Michael Longenecker (5 out of 14 patents)

Wladyslaw A Budzynski (4 out of 4 patents)

R Rao Koganty (4 out of 7 patents)

4. Scott Peterson (2 out of 5 patents)

5. Linda Pestano (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncothyreon Inc.. Retrieved from https://idiyas.com/company/oncothyreon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

9 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]